Screen of receptor and uptake-site activity of hypericin component of St. John's wort reveals σ receptor binding

Life Sciences

Volumn 62, Issue 16, 1998, Pages

  Raffa, Robert B ^a,b  

^a TEMPLE UNIVERSITY   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

Author keywords

receptors; Antidepressants; Hypericin; Receptor assays; St. John's wort; Uptake sites

Indexed keywords

ATROPINE; BUTACLAMOL; CHOLECYSTOKININ OCTAPEPTIDE; ENDOTHELIN 1; GLUTAMIC ACID; HALOPERIDOL; HYPERICIN; HYPERICUM EXTRACT; KETANSERIN; MUSCARINIC RECEPTOR; NICOTINE; SIGMA OPIATE RECEPTOR; TRIPROLIDINE;

ANIMAL TISSUE; AORTA; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FIBROBLAST; GUINEA PIG; HEART; IN VITRO STUDY; LUNG; MOUSE; NONHUMAN; PANCREAS; RAT;

ANTIDEPRESSIVE AGENTS; HUMANS; KINETICS; NEUROTRANSMITTER UPTAKE INHIBITORS; PERYLENE; PLANT EXTRACTS; RADIOLIGAND ASSAY; RECEPTORS, CELL SURFACE; RECEPTORS, SIGMA; SEROTONIN UPTAKE INHIBITORS;

ANIMALIA; CAVIA PORCELLUS; HYPERICUM; HYPERICUM PERFORATUM; SUS SCROFA;

EID: 0032513119     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00085-X     Document Type: Article

References (47)

1. 1. K. LINDE, G. RAMIREZ, C.D. MULROW, A. PAULS and W. WEIDENHAMMER, Br. Med. J. 313 253-258 (1996).
2. 2. H.H. BLOOMFIELD, M. NORDFORS and P. McWILLIAMS, Hypericum & Depression, Prelude Press, Los Angeles (1996).
3. 3. S. PEROVIC and W.E.G. MÜLLER, Arzneim.-Forsch./Drug Res. 45 1145-1148 (1995).
4. 4. W.E. MÜLLER and C.S. SCHÄFER, Deutsche Apoth. Zeitung 136 1015-1022 (1996).
5. 5. H.M. THIEDE and A. WALPER, J. Geriatr. Psychiatr. Neurol. 7 (Suppl. 1) S54-S56 (1994).
6. 6. H. WAGNER and S. BLADT, J. Geriatr. Psychiatr. Neurol. 7 (Suppl. 1) S65-S68 (1994).
7. 7. K.N. KLOTZ, M.J. LOHSE, U. SCHWABE, G. CRISTALLI, S. VITTORI, and M. GRIFANTINI, N-S. Arch. Pharmacol. 340 679-683 (1989).
8. 8. M.F. JARVIS, R. SCHULZ, A.J. HUTCHISON, U.H. DO, M.A. SILLS and M. WILLIAMS, J. Pharmacol. Exp. Ther. 251 888-893 (1989).
9. 9. P. GREENGRASS and R. BREMNER, Eur. J. Pharmacol. 55 323-326 (1979).
10. 10. S. UHLEN and J.E. WIKBERG, Pharmacol. Toxicol. 69 341-350 (1991).
11. 11. T. ABRAHAMSSON, B. EK and V. NERME, Biochem. Pharmacol. 37 203-208 (1988).
12. 12. M. ENTZEROTH and S. HADAMOVSKY, Eur. J. Pharmacol. 206 237-241 (1991).
13. 13. R.C. SPETH, G.J. WASTEK and H.I. YAMAMURA, Life Sci. 24 351-357 (1979).
14. 14. Y.J. JONG, L.R. DALEMAR, B. WILHELM and N.L. BAENZIGER, Proc. Nat'l. Acad. Sci. (USA) 90 10994-10998 (1993).
15. 15. R.S. CHANG and V.J. LOTTI, Proc. Nat'l. Acad. Sci. (USA) 83 4923-4926 (1986).
16. 16. M. TRAMPUS, E. ONGINI, K. VARANI and A. BOREA, Eur. J. Pharmacol. 194 17-23 (1991).
17. 17. M. TERAI, K. HIDAKA and Y. NAKAMURA, Eur. J. Pharmacol. 173 177-182 (1989).
18. 18. K.W. BUCHAN, C. ALLDUS, C. CHRISTODOULOU, K.L. CLARK, C.W. DYKES, M.J. SUMMER, D.M. WALLACE, D.G. WHITE and I.S. WATTS, Br. J. Pharmacol. 112 1251-1257 (1994).
19. 19. A. TSUJI, H. SATO, Y. KUME, I. TAMAI, E. OKESAKI, O. NAGATA and H. KATO, Antimicrob. Agents Chemother. 32 190-194 (1988).
20. 20. M.A. SILLS, G. FAGG, M. POZZA, C. ANGST, D.E. BRUNDISH, S.D. HURT, E.J. WILUSZ and M. WILLIAMS, Eur. J. Pharmacol. 192 19-24 (1991).
21. 21. S. DINI, G.F. CASELLI, M.P. FERRARI, R. GIANI and G. CLAVENNA, Agents Actions 33 181-184 (1991).
22. 22. M.H. RICHARDS, Brit. J. Pharmacol. 99 753-761 (1990).
23. 23. M. A. CASCIERI, E. BER, T.M. FONG, S. SADOWSKI, A. BANSAI, C. SWAIN, E. SEWARD, B. FRANCES, D. BURNS and C.D. STRADER, Mol. Pharmacol. 42 458-463 (1992).
24. 24. M. GOLDSTEIN, N. KUSFINOO, C. ADLER and E. MELLER, Prog. Br. Res. 68 331-335 (1986).
25. 25. L.A. PABREZA, S. DHAWAN and K.J. KELLER, Mol. Pharmacol. 39 9-12 (1991).
26. 26. S.R. CHILDERS, I. CREESE, A.M. SNOWMAN and S.H. SNYDER, Eur. J. Pharmacol. 55 11-18 (1979).
27. 27. J. VIGNON, A. PRIVAT, I. CHAUDIEU, A. THIERRY, J.M. KAMENKA and R. CHICHEPORTICHE, Brain Res. 378 133-141 (1986).
28. 28. S. PEROUTKA and S.H. SNYDER, Mol. Pharmacol. 16 687-699 (1979).
29. 29. D. HOYER, G. ENGEL and H.O. KALKMAN, Eur. J. Pharmacol. 118 1-12 (1985).
30. 30. J.E. LEYSEN, C.J.E. NIEMEGEERS, J.M. VAN NUETEN and P.M. LADURON, Mol. Pharmacol. 21 301-314 (1982).
31. 31. Y. SHIRAYAMA, T. NISHIKAWA, A. UMINO and K. TAKAHASHI, Eur. J. Pharmacol. 237 117-126 (1993).
32. 32. S. MESHINCHI, E.R. SANCHEZ, K.J. MARTELL and W.B. PRATT, J. Biol. Chem. 265 4863-4870 (1990).
33. 33. M. THIBONNIER, A.L. BAYER, M.S. SIMONSON and M. KESTER, Endocrinol. 129 2845-2856 (1991).
34. 34. J.O. MARCUSSON, M. BERGSTROM, K. ERIKSSON and S.V. ROSS, J. Neurochem. 50 1783-1790 (1988).
35. 35. S.M. TEJANI-BUTT, J. Pharmacol. Exp. Ther. 260 427-436 (1992).
36. 36. J. VIGNON, A. PRIVAT, I. CHAUDIEU, A. THIERRY, J.M. KAMENKA and R. CHICHEPORTICHE, Brain Res. 378 133-141 (1986).
37. 37. W.E. MÜLLER and R. ROSSOL, J. Geriatr. Psychiatr. Neurol. 7 (Suppl. 1) S63-S64 (1994).
38. 38. M. KLEIN and J.M. MUSACCHIO, J. Pharmacol. Exp. Ther., 251 207-215 (1989).
39. 39. A. SCHMIDT, L. LEBEL, B.K. KOE, T. SEEGER and J. HEYM, Eur. J. Pharmacol. 165 335-336 (1989).
40. 40. Y. ITZHAK and C.O. KASSIM, Eur. J. Pharmacol. 176 107-108 (1990).
41. 41. Y. ITZHAK and I. STEIN, Life Sci. 47 1073-1081 (1990).
42. 42. T.S. RAO, J.A. CLER, S.J. MICK, D.M. RAGAN, T.H. LANTHORN, P.C. CONTRERAS, S. IYENGAR and P.L. WOOD, Neuropharmacol. 29 1199-1204 (1990).
43. 43. B.E. LEONARD, C. SONG and B. EARLEY, Neuropsychopharmacol. 10 838s (1994).
44. 44. W.S. TAM, Sigma Receptors, Y. Itzhak (ed.), 191-204, Academic Press, New York (1994).
45. 45. Y. SHIRAYAMA, T. NISHIKAWA, A. UMINO and K. TAKAHASHI, Eur. J. Pharmacol. 237 117-126 (1993).
46. 46. G. DEBONNEL and C. de MONTIGNY, Life Sci. 58 721-734 (1996).
47. 47. B.E. LEONARD, Fundamentals of Psychopharmacology, 2nd ed., 345-349, John Wiley & Sons, Chichester, (1997).